B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion.

Asslaber, D; Qi, Y; Maeding, N; Steiner, M; Denk, U; Hopner, JP; Hartmann, TN; Zaborsky, N; Greil, R; Egle, A

View this publication in the PUBMED database